01—History
Shares Outstanding History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- 100.1M
1 older move runs past ±20% (largest +20.2%); point at, tap or drag across the bars to read one.
02—Ledger
Shares Outstanding, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | 100.1M | +0.7% | 10-K | |
| FY2024 | 99.4M | +0.7% | 10-K | |
| FY2023 | 98.7M | +2.3% | 10-K | |
| FY2022 | 96.5M | +1.7% | 10-K | |
| FY2021 | 94.9M | +1.5% | 10-K | |
| FY2020 | 93.5M | +1.3% | 10-K | |
| FY2019 | 92.3M | +1.7% | 10-K | |
| FY2018 | 90.8M | +2.3% | 10-K | |
| FY2017 | 88.8M | +2.2% | 10-K | |
| FY2016 | 86.9M | +0.7% | 10-K | |
| FY2015 | 86.3M | +12.8% | 10-K | |
| FY2014 | 76.5M | +13.5% | 10-K | |
| FY2013 | 67.4M | +1.4% | 10-K | |
| FY2012 | 66.4M | +20.2% | 10-K | |
| FY2011 | 55.3M | +0.7% | 10-K | |
| FY2010 | 54.9M | — | 10-K |
03—Questions
What is shares outstanding?
Shares outstanding is the total number of common shares currently held by all shareholders, including restricted shares.
What is Neurocrine Biosciences's current shares outstanding?
Neurocrine Biosciences (NBIX) annual shares outstanding for 2025 was 100.1M, a 0.70% increase from 2024. Neurocrine Biosciences shares outstanding for the quarter ending September 30, 2026 was 101.3M.
What was Neurocrine Biosciences's shares outstanding in 2024?
Neurocrine Biosciences annual shares outstanding for 2024 was 99.4M, a 0.71% increase from 2023.
What was Neurocrine Biosciences's shares outstanding in 2023?
Neurocrine Biosciences annual shares outstanding for 2023 was 98.7M, a 2.28% increase from 2022.
What is Neurocrine Biosciences's 5-year shares outstanding CAGR?
Neurocrine Biosciences shares outstanding grew at a compound annual growth rate (CAGR) of 1.37% from FY2020 to FY2025, going from 93.5M to 100.1M over 5 years.
- Company
- Neurocrine Biosciences
- Ticker
- NBIX
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)